Publication Date:
2015
abstract:
Production of monoclonal antibodies (mAbs) involving human-mouse hybrid cells was first described in 1970s, but these biologics are now used for a variety of diseases including cancers, autoimmune disorders and allergic diseases. The aim of this article is to review current and future applications of mAbs, in particular focusing on anti-IgE therapy, in the field of pediatric allergy.
Iris type:
1.1 Articolo in rivista
Keywords:
Monoclonal antibodies (mAbs); severe asthma; chronic spontaneous urticaria; anti-IgE mAbs; omalizumab
List of contributors:
Licari, Amelia; Castagnoli, Riccardo; Marseglia, Alessia; Bottino, Chiara; Corana, Giulia; Guerini, Paola; Zaroli, Arianna; Caimmi, Silvia; Marseglia, GIAN LUIGI
Published in: